Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Masco
MAS
$14.6B
| $8.13M | 0.01% |
+161,991
| New | +$7.02M |
|
1352
CTS Corp
CTS
$1.81B
| $8.12M | 0.01% |
405,400
+142,300
| +54% | +$3.05M |
|
1353
Tenable Holdings
TENB
$4.26B
| $8.12M | 0.01% |
+272,400
| New | +$7.4M |
|
1354
Kulicke & Soffa
KLIC
$5.05B
| $8.1M | 0.01% |
388,991
-195,709
| -33% | -$4.43M |
|
|
PSB
1355
DELISTED
PS Business Parks, Inc.
PSB
| $8.09M | 0.01% |
61,100
+37,700
| +161% | +$4.84M |
|
1356
Pool Corp
POOL
$7.14B
| $8.08M | 0.01% |
29,736
+10,136
| +52% | +$2.35M |
|
1357
Wintrust Financial
WTFC
$11B
| $8.07M | 0.01% |
185,000
-122,000
| -40% | -$4.87M |
|
1358
First Bancorp
FBNC
$2.75B
| $8.02M | 0.01% |
319,914
-90,700
| -22% | -$2.18M |
|
1359
Ferrari
RACE
$72.7B
| $8.02M | 0.01% |
46,900
+29,900
| +176% | +$4.82M |
|
1360
American States Water
AWR
$3.5B
| $8.01M | 0.01% |
101,900
+30,700
| +43% | +$2.45M |
|
|
SREV
1361
DELISTED
ServiceSource International, Inc.
SREV
| $7.98M | 0.01% |
5,050,261
+703,804
| +16% | +$960K |
|
1362
NACCO Industries
NC
$318M
| $7.97M | 0.01% |
342,246
-3,277
| -0.9% | -$88.3K |
|
|
MRSN
1363
DELISTED
Mersana Therapeutics
MRSN
| $7.96M | 0.01% |
13,611
-17,732
| -57% | -$6.06M |
|
|
WSR
1364
DELISTED
Whitestone REIT
WSR
| $7.96M | 0.01% |
1,094,684
-886,493
| -45% | -$5.64M |
|
1365
Culp Inc
CULP
$43.8M
| $7.95M | 0.01% |
923,817
+97,100
| +12% | +$690K |
|
1366
QuinStreet
QNST
$1.19B
| $7.93M | 0.01% |
758,000
+326,400
| +76% | +$3.15M |
|
|
THR
1367
DELISTED
Thermon Group Holdings
THR
| $7.9M | 0.01% |
542,490
-39,910
| -7% | -$591K |
|
|
AE
1368
DELISTED
Adams Resources & Energy Inc
AE
| $7.89M | 0.01% |
294,843
-5,933
| -2% | -$156K |
|
1369
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $7.89M | 0.01% |
+279,600
| New | +$8.06M |
|
|
VRTU
1370
DELISTED
Virtusa Corporation
VRTU
| $7.88M | 0.01% |
242,696
-44,200
| -15% | -$1.37M |
|
|
CUTR
1371
DELISTED
Cutera, Inc.
CUTR
| $7.88M | 0.01% |
647,300
-20,500
| -3% | -$270K |
|
|
NBSE
1372
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $7.87M | 0.01% |
44,804
+25,730
| +135% | +$4.31M |
|
|
FFIC
1373
DELISTED
Flushing Financial
FFIC
| $7.85M | 0.01% |
681,660
-50,600
| -7% | -$579K |
|
|
HMLP
1374
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $7.85M | 0.01% |
806,469
-187,700
| -19% | -$1.83M |
|
|
VEDL
1375
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $7.83M | 0.01% |
1,395,920
-1,294,000
| -48% | -$6.12M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.